| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.041 | 0.9 |